Edition:
United States

Stephanie Nebehay

Global foreign direct investment halved in first six months of 2020, U.N. says

Oct 27 2020

GENEVA Global foreign direct investment (FDI) plunged by 49% in the first half of 2020 from the same period a year ago and is on course to fall as much as 40% for the year, driven by fears of a deep recession, the United Nations said on Tuesday.

UPDATE 2-Europe needs 'serious acceleration' in fight against coronavirus - WHO

Oct 26 2020

GENEVA, Oct 26 Europe needs a "serious acceleration" in the fight against the coronavirus and a lack of contact-tracing capacity could drive the disease into the darkness, a top World Health Organization official said on Monday.

WHO: Nations mulling Gilead's COVID drug should consider trial flop, too

Oct 23 2020

GENEVA/ZURICH Health officials reviewing Gilead Science Inc's remdesivir against COVID-19 should consider all evidence, including a trial in which the medicine failed, before giving it the green light, the top WHO scientist said on Friday.

Risk of inflight spread of COVID-19 'very low', not zero: WHO

Oct 22 2020

GENEVA The risk of COVID-19 spreading on flights appears "very low" but cannot be ruled out, despite studies showing only a small number of cases, the World Health Organization (WHO) said.

U.N. acting Libya envoy 'optimistic' on ceasefire talks

Oct 21 2020

GENEVA The United Nations' acting Libya envoy said on Wednesday she was "quite optimistic" that ongoing talks between the warring sides would lead to a lasting ceasefire, after they agreed to reopen land and air routes across front lines.

Europe, North America should learn from Asia on COVID-19 - WHO expert

Oct 19 2020

GENEVA Europe and North America should follow the example of Asian states by persevering with anti-COVID measures and quarantining anyone who comes into contact with infected people, a World Health Organization (WHO) expert said on Monday.

Row breaks out over WHO trial casting doubt on remdesivir as COVID-19 drug

Oct 16 2020

ZURICH/GENEVA A row broke out on Friday over a World Health Organization (WHO) clinical trial which concluded that the anti-viral drug remdesivir has little or no impact on a patient's chances of surviving COVID-19.

Row breaks out over WHO trial casting doubt on remdesivir as COVID-19 drug

Oct 16 2020

ZURICH/GENEVA A row broke out on Friday over a World Health Organization (WHO) clinical trial which concluded that the anti-viral drug remdesivir has little or no impact on a patient's chances of surviving COVID-19.

World News